HANNAH KERMAN: Open Payments
NPI 1184368896 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 71 payments from 20 companies in 2025. Trend: 2023 $313 · 2024 $1,311 · 2025 $1,605
Food & beverage: $1,605
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $261 |
| Regeneron Healthcare Solutions, Inc. | 14 | $227 |
| Novartis Pharmaceuticals Corporation | 9 | $191 |
| GENZYME CORPORATION | 2 | $146 |
| ANI Pharmaceuticals, Inc. | 5 | $140 |
| Amgen Inc. | 5 | $98 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $98 |
| Organon LLC | 8 | $86 |
| Genentech USA, Inc. | 3 | $72 |
| Blueprint Medicines Corporation | 2 | $53 |
Products named: DUPIXENT, PURIFIED CORTROPHIN GEL, AIRSUPRA, TEZSPIRE, NEFFY, Xolair, FASENRA, AYVAKIT.
Industry payments across TX — which companies pay providers there.
